Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Compound oral liquid capable of treating cholecystitis and preparation method thereof

A technology for oral liquid and cholecystitis, which is applied in the field of compound oral liquid for treating cholecystitis and its preparation, can solve the problems of drug resistance, side effects, and decreased resistance in the body, achieve good clinical effects, relieve pain, The effect of increasing resistance

Inactive Publication Date: 2016-06-22
杜乐栋
View PDF9 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The combined application of multiple antibiotics and pain-relieving drugs will reduce the resistance of the body, and at the same time make the body resistant to drugs, and long-term use will cause side effects. Can produce drug resistance, but also enhance the body's immunity

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0018] A compound oral liquid for treating cholecystitis, mainly comprising: 30 parts of taurocholic acid, 26 parts of serrapeptase, 24 parts of oleanolic acid, 22 parts of ginkgo leaf extract and 22 parts of gallic acid in terms of components by weight , 19 parts of apigenin, 16 parts of folic acid, 15 parts of serine, 12 parts of vitamin C, 10 parts of stigmasterol, 8 parts of ketone, 40 parts of simple syrup, 30 parts of honey, and 800 parts of distilled water; the compound oral liquid also includes auxiliary materials : 16 parts of sweetener, 12 parts of suspending agent, 9 parts of wetting agent, 7 parts of preservative.

[0019] Wherein, the active ingredients of the Ginkgo biloba extract are total flavonoids of Ginkgo biloba and ginkgolides, and the preparation method is as follows: after cleaning the Ginkgo biloba leaves, air-dry them naturally at room temperature, then smash them into pieces, pour 5 times the amount of alcohol solution, The alcohol solution is prepare...

Embodiment 2

[0024] A compound oral liquid for treating cholecystitis, mainly comprising: 45 parts of taurocholic acid, 40.5 parts of serrapeptase, 38 parts of oleanolic acid, 36 parts of ginkgo leaf extract and 34 parts of gallic acid in terms of components by weight , 32 parts of apigenin, 27 parts of folic acid, 25 parts of serine, 21 parts of vitamin C, 17 parts of stigmasterol, 14 parts of ketone, 60 parts of simple syrup, 50 parts of honey, and 900 parts of distilled water; the compound oral liquid also includes auxiliary materials : 20.5 parts of sweetener, 15 parts of suspending agent, 12 parts of wetting agent, 10 parts of preservative.

[0025] Wherein, the active ingredients of the Ginkgo biloba extract are total flavonoids of Ginkgo biloba and ginkgolides, and the preparation method is as follows: After cleaning the Ginkgo biloba leaves, air-dry them naturally at room temperature, then mash them, pour 6.5 times the amount of alcohol solution, The alcohol solution is prepared by...

Embodiment 3

[0030] A compound oral liquid for treating cholecystitis, mainly comprising: 60 parts of taurocholic acid, 55 parts of serrapeptase, 52 parts of oleanolic acid, 50 parts of ginkgo leaf extract and 46 parts of gallic acid in terms of components by weight , 45 parts of apigenin, 38 parts of folic acid, 35 parts of serine, 30 parts of vitamin C, 24 parts of stigmasterol, 20 parts of ketone, 80 parts of simple syrup, 70 parts of honey, 1000 parts of distilled water; the compound oral liquid also includes auxiliary materials : 25 parts of sweetener, 18 parts of suspending agent, 15 parts of wetting agent, 13 parts of preservative.

[0031] Wherein, the active ingredients of the Ginkgo biloba extract are total flavonoids of Ginkgo biloba and ginkgolides, and the preparation method is as follows: After cleaning the Ginkgo biloba leaves, air-dry them naturally at room temperature, then smash them into pieces, pour 8 times the amount of alcohol solution, The alcohol solution is prepare...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses compound oral liquid capable of treating cholecystitis and a preparation method thereof. The compound oral liquid mainly comprises taurocholic acid, serrapetase, oleanolic acid, ginkgo biloba extract, gallate, apigenin, folic acid, serine, vitamin C, stigmasterol, elsholtzia ketone, simple syrup, honey and distilled water, and further comprises the following auxiliary materials: a sweetening agent, a suspending agent, a wetting agent and a preservative. The compound oral liquid has relatively good antisepsis and anti-inflammation effects, a favorable gallbladder nourishing effect, a favorable pain relief effect and a favorable cholesterol secretion regulation effect, and is capable of dredging biliary ducts, promoting fat metabolism of muscle bodies, effectively improving the immunity of the muscle bodies, meanwhile enhancing the activity of gall bladder cells, and reducing cholesterol deposition so as to prevent gallstones; western and traditional Chinese medicines are effectively combined, so that the medical effect is mild and stable, untoward effect is avoided, and the compound oral liquid has a favorable clinical effect in prevention and treatment of the cholecystitis.

Description

technical field [0001] The invention relates to the technical field of gallbladder medication, in particular to a compound oral liquid for treating cholecystitis and a preparation method thereof. Background technique [0002] Cholecystitis is a clinically common disease with a high incidence in today's society. According to its clinical manifestations and clinical course, it is divided into acute and chronic types: Acute calculous cholecystitis has multiple clinical manifestations: stones or parasites incarcerated to block the neck of the gallbladder, sudden onset of pain, very severe, accompanied by Nausea, vomiting, chills, chills, fever, jaundice and other complication symptoms usually occur after eating high-fat food; chronic cholecystitis clinically manifests as persistent dull pain or discomfort in the right upper quadrant, accompanied by nausea, belching, acid regurgitation , abdominal distension, heartburn, etc., together with pain in the right lower scapular region...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K38/48A61K9/08A61P1/16A61K36/16A61K35/644A61K31/7004A61K31/575A61K31/56A61K31/519A61K31/375A61K31/352A61K31/341A61K31/198A61K31/192
CPCA61K38/48A61K9/08A61K31/192A61K31/198A61K31/341A61K31/352A61K31/375A61K31/519A61K31/56A61K31/575A61K31/7004A61K35/644A61K36/16A61K2236/33A61K2236/331A61K2236/51A61K2300/00
Inventor 杜乐栋于群刘金军
Owner 杜乐栋
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com